Fractionated palliative thoracic radiotherapy in non-small cell lung cancer – futile or worth-while?
Abstract Background Palliative thoracic radiotherapy (PTR) can relieve symptoms originating from intra-thoracic disease. The optimal timing and fractionation of PTR is unknown. Time to effect is 2 months. The primary aim of this retrospective study was to investigate survival after PTR, hypothesizin...
Main Authors: | Malene Støchkel Frank, Dorte Schou Nørøxe, Lotte Nygård, Gitte Fredberg Persson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-01-01
|
Series: | BMC Palliative Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12904-017-0270-4 |
Similar Items
-
A comparative study of different dose fractionations schedule of thoracic radiotherapy for pain palliation and health-related quality of life in metastatic NSCLC
by: Sourav Sau, et al.
Published: (2014-01-01) -
Comparison of Palliative Fractionated Radiotherapy to Thorax in Non-small Cell Lung Carcinoma: A Prospective Comparative Study
by: Mayur Khandelwal, et al.
Published: (2024-01-01) -
Outpatient Embedded Palliative Care for Patients with Advanced Thoracic Malignancy: A Retrospective Cohort Study
by: Mary C. Boulanger, et al.
Published: (2024-03-01) -
Dignity of individuals with dementia, palliative care, and futile treatment
by: Novotný Rudolf, et al.
Published: (2023-06-01) -
Futile Medication in Palliative Cancer Patients; a Report from the Middle East
by: Hamed Mahzoni, et al.
Published: (2023-04-01)